ACE inhibitors can induce circulating antibodies directed to antigens of the superficial epidermal cells

Arch Dermatol Res. 2011 Jul;303(5):327-32. doi: 10.1007/s00403-010-1060-5. Epub 2010 Jun 20.

Abstract

Drug-induced pemphigus has been reported in patients receiving angiotensin-converting enzyme inhibitors. The aim of this work was to study a group of hypertensive patients without skin diseases treated with angiotensin-converting enzyme (ACE) Inhibitors (I), to verify the presence of serum circulating anti-antibodies. The indirect immunofluorescence showed that 33 sera (52.38%) presented autoantibodies directed to an antigen of the cytoplasm of the superficial epidermal keratinocytes. Two of the 33 positive sera had antibodies to Dsg1 and/or 3 in ELISA. Immunoblot analyses were negative. All the 48 control sera were found to have no circulating antibodies using the three assays. Our results would confirm that ACEI drugs may trigger the production of circulating autoantibodies also in patients without clinical manifestations of pemphigus.

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antibodies, Anti-Idiotypic / blood
  • Antibody Formation
  • Antigens / immunology*
  • Autoantibodies / blood*
  • Autoantibodies / immunology
  • Desmoglein 1 / immunology
  • Desmoglein 3 / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Epidermis / immunology
  • Female
  • Fluorescent Antibody Technique, Indirect
  • Humans
  • Hypertension / drug therapy
  • Immunoblotting
  • Keratinocytes / immunology*
  • Male
  • Pemphigus / immunology
  • Skin Diseases / chemically induced*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antibodies, Anti-Idiotypic
  • Antigens
  • Autoantibodies
  • DSG1 protein, human
  • DSG3 protein, human
  • Desmoglein 1
  • Desmoglein 3